{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-075016","form_type":"8-K","ticker":"GRML","cik":"0001907223","company_name":"Greenland Mines Ltd","filed_at":"2025-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.569493+00:00","generated_at":"2026-05-17T14:54:13.289215+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Klotho Neurosciences signs $250K manufacturing deal with AAVnerGene for KLTO-202 gene therapy","bullets":["Initial fees of $250,000; additional fees tied to clinical trial stages plus 2% royalty on product revenue.","Agreement covers manufacturing and development of KLTO-202 using AAVnerGene's AAVone platform technology.","AAVnerGene's ATHENA tissue-targeting system aims to avoid liver homing and reduce inflammatory side effects.","CEO states partnership expected to lower cost, increase purity, and accelerate time to clinic."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-075016","json":"https://secwatch.observer/filing/0001213900-25-075016.json","markdown":"https://secwatch.observer/filing/0001213900-25-075016.md","text":"https://secwatch.observer/filing/0001213900-25-075016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1907223/000121390025075016/0001213900-25-075016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1907223/000121390025075016/ea0252863-8k_klotho.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T14:54:13.289215+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}